CAS 2732926-27-9

1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-

Description:

1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]- is a chemical compound characterized by its complex structure, which includes a benzimidazole core, an ethanamine group, and a substituted phenyl moiety. This compound typically exhibits properties associated with both aromatic and aliphatic systems, contributing to its potential biological activity. The presence of the benzimidazole ring suggests possible applications in pharmaceuticals, particularly in areas related to anti-cancer or anti-inflammatory activities, as benzimidazole derivatives are known for their diverse pharmacological properties. The diethylamine group may enhance solubility and bioavailability, while the 4-(1-methylethoxy)phenyl substitution could influence the compound's interaction with biological targets. Overall, the structural features of this compound suggest it may possess unique chemical reactivity and biological activity, making it of interest in medicinal chemistry and drug development. However, specific studies would be necessary to elucidate its precise characteristics and potential applications.

Formula: C₂₃H₃₁N₃O

Synonyms:

• 1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-

Isotodesnitazene

CAS: 2732926-27-9

Isotodesnitazene is an opioid compound that primarily targets the μ-opioid receptor (MOR). It exhibits EC50 values of 34.8 nM and 142 nM for MOR-βarr2 and MOR-mini-Gi, respectively. Isotodesnitazene can be utilized for research in opioid drugs.

Formula: C₂₃H₃₁N₃O

Color and Shape: Solid

Molecular weight: 365.51

Ref: TM-T201840